PROFESSIONAL EDITION

The largest community of pharma leaders

Subscribe to Our News!

Regulatory Affairs

Industry News

Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)

KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) Source Business Wire Health: Pharmaceutical NewsRead More
Admin - 0
Read more
Regulatory Affairs

Applied DNA Promotes Judith Murrah to Chief Operating Officer

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced...
Admin - 0
Read more
Regulatory Affairs

U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® (nivolumab) as Adjuvant Therapy for Patients with Resected Esophageal or Gastroesophageal Junction...

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--U.S. FDA Accepts for Priority Review Application for Opdivo as Adjuvant Therapy for Patients w/Resected Esophageal or Gastroesophageal Junction Cancer...
Admin - 0
Read more
Regulatory Affairs

ENHERTU® Approved in the EU for the Treatment of HER2 Positive Metastatic Breast Cancer

TOKYO & MUNICH--(BUSINESS WIRE)--ENHERTU® Approved in the EU for the Treatment of HER2 Positive Metastatic Breast Cancer Source Read More
Admin - 0
Read more
Regulatory Affairs

Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) announced today that the Biologics License Application (BLA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic...
Admin - 0
Read more
Regulatory Affairs

Taysha Gene Therapies Receives Rare Pediatric Disease and Orphan Drug Designations for TSHA-105 for the Treatment of Epilepsy Caused by SLC13A5 Deficiency

Taysha Gene Therapies Receives Rare Pediatric Disease and Orphan Drug Designations for TSHA-105 for the Treatment of Epilepsy Caused by SLC13A5 Deficiency Designations reinforce unmet...
Admin - 0
Read more
123...29Page 1 of 29

Recent Articles

Frank Neumann, M.D., Ph.D., to Depart Verastem Oncology

Look Who’s On the Move!

Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)

Industry News

U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® (nivolumab) as Adjuvant Therapy for Patients with Resected Esophageal or Gastroesophageal Junction...

Regulatory Affairs

Applied DNA Promotes Judith Murrah to Chief Operating Officer

Regulatory Affairs

Forma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating FT-7051 for the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)

Clinical Trials

Turnstone Biologics Acquires Novel Cell Therapy Platform

Hospital News

Talaris Therapeutics Adds Two Experienced Biotechnology Executives to its Board of Directors

Look Who’s On the Move!

Forma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating FT-7051 for the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)

Clinical Trials

Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by...

Clinical Trials

ENHERTU® Approved in the EU for the Treatment of HER2 Positive Metastatic Breast Cancer

Regulatory Affairs

Ipsen Appoints Gwenan White as Executive Vice President, Communications and Public Affairs

Look Who’s On the Move!

CIRCULOGENE Appoints Stephen Unger Chief Financial Officer

Look Who’s On the Move!

Prosetta Biosciences Announces Novel Solution to COVID-19 Crisis

Industry News

Nilesh Patel Joins Cellanyx Board of Directors

Look Who’s On the Move!

New Vaccination Cart from Ergotron Supports COVID-19 Vaccine Distribution Inside and Outside of Clinics

Industry News

2020 © Copyright - TPMG